• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

民主化基因组学:利用软件使遗传学成为常规护理的一个组成部分。

Democratizing genomics: Leveraging software to make genetics an integral part of routine care.

机构信息

Invitae, San Francisco, California, USA.

出版信息

Am J Med Genet C Semin Med Genet. 2021 Mar;187(1):14-27. doi: 10.1002/ajmg.c.31866. Epub 2020 Dec 9.

DOI:10.1002/ajmg.c.31866
PMID:33296144
Abstract

Genetic testing can provide definitive molecular diagnoses and guide clinical management decisions from preconception through adulthood. Innovative solutions for scaling clinical genomics services are necessary if they are to transition from a niche specialty to a routine part of patient care. The expertise of specialists, like genetic counselors and medical geneticists, has traditionally been relied upon to facilitate testing and follow-up, and while ideal, this approach is limited in its ability to integrate genetics into primary care. As individuals, payors, and providers increasingly realize the value of genetics in mainstream medicine, several implementation challenges need to be overcome. These include electronic health record integration, patient and provider education, tools to stay abreast of guidelines, and simplification of the test ordering process. Currently, no single platform offers a holistic view of genetic testing that streamlines the entire process across specialties that begins with identifying at-risk patients in mainstream care settings, providing pretest education, facilitating consent and test ordering, and following up as a "genetic companion" for ongoing management. We describe our vision for using software that includes clinical-grade chatbots and decision support tools, with direct access to genetic counselors and pharmacists within a modular, integrated, end-to-end testing journey.

摘要

遗传检测可提供明确的分子诊断,并为从受孕前到成年期的临床管理决策提供指导。如果要将临床基因组学服务从一个利基专业转变为患者护理的常规部分,就需要创新的解决方案来扩展这些服务。遗传咨询师和医学遗传学家等专家的专业知识一直以来都被用于促进检测和随访,虽然这种方法很理想,但它在将遗传学纳入初级保健方面的能力有限。随着个人、支付方和提供者越来越认识到遗传学在主流医学中的价值,需要克服几个实施方面的挑战。这些挑战包括电子健康记录的整合、患者和提供者的教育、了解指南的工具以及简化检测订购流程。目前,没有任何单一平台可以提供遗传检测的整体视图,无法简化整个流程,而整个流程始于在主流护理环境中识别高危患者,提供检测前教育,促进同意和检测订购,并作为“遗传伴侣”为持续管理提供帮助。我们描述了我们使用软件的愿景,该软件包括临床级别的聊天机器人和决策支持工具,并可直接访问遗传咨询师和药剂师,以实现模块化、集成的端到端检测流程。

相似文献

1
Democratizing genomics: Leveraging software to make genetics an integral part of routine care.民主化基因组学:利用软件使遗传学成为常规护理的一个组成部分。
Am J Med Genet C Semin Med Genet. 2021 Mar;187(1):14-27. doi: 10.1002/ajmg.c.31866. Epub 2020 Dec 9.
2
Critical components of genomic medicine practice for non-genetics healthcare professionals: Genetic counselors' perspectives and implications for medical education.基因组医学实践对非遗传学医疗保健专业人员的关键要求:遗传咨询师的观点及其对医学教育的意义。
J Genet Couns. 2023 Aug;32(4):798-811. doi: 10.1002/jgc4.1689. Epub 2023 Feb 20.
3
Novel genetic testing model: A collaboration between genetic counselors and nephrology.新型基因检测模式:遗传咨询师与肾病学的合作
Am J Med Genet A. 2021 Apr;185(4):1142-1150. doi: 10.1002/ajmg.a.62088. Epub 2021 Jan 21.
4
Are providers prepared for genomic medicine: interpretation of Direct-to-Consumer genetic testing (DTC-GT) results and genetic self-efficacy by medical professionals.医务人员对直接面向消费者的基因检测(DTC-GT)结果的解读和遗传自我效能的准备情况如何。
BMC Health Serv Res. 2019 Nov 25;19(1):844. doi: 10.1186/s12913-019-4679-8.
5
Elective genomic testing: Practice resource of the National Society of Genetic Counselors.选择性基因组检测:美国国家遗传咨询师协会的实践资源。
J Genet Couns. 2023 Apr;32(2):281-299. doi: 10.1002/jgc4.1654. Epub 2023 Jan 4.
6
Patient assessment of chatbots for the scalable delivery of genetic counseling.用于可扩展基因咨询服务的聊天机器人的患者评估
J Genet Couns. 2019 Dec;28(6):1166-1177. doi: 10.1002/jgc4.1169. Epub 2019 Sep 24.
7
Adverse Events in Genetic Testing: The Fourth Case Series.遗传检测中的不良事件:第四病例系列。
Cancer J. 2019 Jul/Aug;25(4):231-236. doi: 10.1097/PPO.0000000000000391.
8
Scaling Genetic Counseling in the Genomics Era.基因时代的遗传咨询扩展。
Annu Rev Genomics Hum Genet. 2021 Aug 31;22:339-355. doi: 10.1146/annurev-genom-110320-121752. Epub 2021 Mar 15.
9
Genetic Testing Practices of Genetic Counselors, Geneticists, and Pediatric Neurologists With Regard to Childhood-Onset Neurogenetic Conditions.遗传咨询师、遗传学家和儿科神经科医生针对儿童期起病的神经遗传疾病的基因检测实践。
J Child Neurol. 2019 Mar;34(4):177-183. doi: 10.1177/0883073818821036. Epub 2019 Jan 4.
10
Challenges and Errors in Genetic Testing: The Fifth Case Series.遗传检测中的挑战和错误:第五个病例系列。
Cancer J. 2021;27(6):417-422. doi: 10.1097/PPO.0000000000000553.

引用本文的文献

1
Implementing a chatbot to promote hereditary breast & ovarian cancer genetic screening in women's health: identifying barriers and facilitators to screening adoption.实施聊天机器人以促进女性健康领域的遗传性乳腺癌和卵巢癌基因筛查:识别筛查采用的障碍和促进因素。
BMC Public Health. 2025 Jul 19;25(1):2516. doi: 10.1186/s12889-025-23488-4.
2
Interpretative phenomenological analysis and genetic counseling.诠释现象学分析与遗传咨询
J Genet Couns. 2025 Jun;34(3):e70061. doi: 10.1002/jgc4.70061.
3
Psychological and behavioural considerations for integrating polygenic risk scores for disease into clinical practice.
将疾病多基因风险评分纳入临床实践的心理和行为学考量
Nat Hum Behav. 2025 May 12. doi: 10.1038/s41562-025-02200-x.
4
Social vulnerability and genetic service utilization among unaffected BRIDGE trial patients with inherited cancer susceptibility.遗传性癌症易感性未受影响的BRIDGE试验患者的社会脆弱性与基因服务利用情况
BMC Cancer. 2025 Jan 31;25(1):180. doi: 10.1186/s12885-025-13495-4.
5
Developing and Assessing a Scalable Digital Health Tool for Pretest Genetic Education in Patients With Early-Onset Colorectal Cancer: Mixed Methods Design.开发和评估一种用于早发性结直肠癌患者检测前基因教育的可扩展数字健康工具:混合方法设计
JMIR Cancer. 2025 Jan 17;11:e59464. doi: 10.2196/59464.
6
Artificial intelligence in clinical genetics.临床遗传学中的人工智能
Eur J Hum Genet. 2025 Mar;33(3):281-288. doi: 10.1038/s41431-024-01782-w. Epub 2025 Jan 13.
7
Utilizing innovative implementation strategies for familial hypercholesterolemia: Implementation outcomes from the IMPACT-FH study.利用创新的家族性高胆固醇血症实施策略:IMPACT-FH 研究的实施结果。
J Clin Lipidol. 2024 Sep-Oct;18(5):e832-e843. doi: 10.1016/j.jacl.2024.07.011. Epub 2024 Jul 31.
8
Protocol for a type 3 hybrid implementation cluster randomized clinical trial to evaluate the effect of patient and clinician nudges to advance the use of genomic medicine across a diverse health system.一种 3 型混合实施集群随机临床试验的方案,旨在评估患者和临床医生提示在多样化医疗体系中推进基因组医学应用的效果。
Implement Sci. 2024 Aug 19;19(1):61. doi: 10.1186/s13012-024-01385-5.
9
The NYCKidSeq randomized controlled trial: Impact of GUÍA digitally enhanced genetic results disclosure in diverse families.NYCKidSeq 随机对照试验:GUÍA 数字化增强遗传结果披露对不同家庭的影响。
Am J Hum Genet. 2023 Dec 7;110(12):2029-2041. doi: 10.1016/j.ajhg.2023.10.016. Epub 2023 Nov 24.
10
Navigating the uncertainty of precision cancer screening: The role of shared decision-making.应对精准癌症筛查的不确定性:共同决策的作用。
PEC Innov. 2023 Jan 24;2:100127. doi: 10.1016/j.pecinn.2023.100127. eCollection 2023 Dec.